UroGen Pharma Correlations
URGN Stock | USD 9.46 0.17 1.83% |
A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as UroGen Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if UroGen Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
UroGen Pharma Correlation With Market
Very weak diversification
The correlation between UroGen Pharma and DJI is 0.4 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding UroGen Pharma and DJI in the same portfolio, assuming nothing else is changed.
UroGen |
Moving together with UroGen Stock
0.61 | ILMN | Illumina Sell-off Trend | PairCorr |
0.88 | KURA | Kura Oncology | PairCorr |
0.83 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.82 | ADTX | Aditxt Inc | PairCorr |
0.72 | RYTM | Rhythm Pharmaceuticals | PairCorr |
0.68 | ANAB | AnaptysBio Earnings Call Next Week | PairCorr |
0.9 | STRO | Sutro Biopharma | PairCorr |
0.86 | TCRX | Tscan Therapeutics | PairCorr |
0.74 | TERN | Terns Pharmaceuticals | PairCorr |
0.77 | CRNX | Crinetics Pharmaceuticals Buyout Trend | PairCorr |
0.69 | CTMX | CytomX Therapeutics Earnings Call Next Week | PairCorr |
0.81 | DAWN | Day One Biopharmaceu | PairCorr |
Moving against UroGen Stock
0.51 | PFE | Pfizer Inc | PairCorr |
0.51 | PHGE | Biomx Inc | PairCorr |
0.4 | GANX | Gain Therapeutics | PairCorr |
0.38 | OPT | Opthea | PairCorr |
0.31 | FENC | Fennec Pharmaceuticals | PairCorr |
0.31 | CUE | Cue Biopharma | PairCorr |
0.31 | LTRN | Lantern Pharma | PairCorr |
0.51 | CGTX | Cognition Therapeutics | PairCorr |
0.45 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
0.73 | SSNLF | Samsung Electronics | PairCorr |
0.62 | OBI | Ondine Biomedical | PairCorr |
0.44 | EC | Ecopetrol SA ADR Sell-off Trend | PairCorr |
0.4 | KO | Coca Cola | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between UroGen Stock performing well and UroGen Pharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze UroGen Pharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ELYM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
INBX | 2.46 | (0.01) | 0.00 | (0.04) | 0.00 | 5.54 | 16.41 | |||
MACK | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
CELC | 2.63 | (0.38) | 0.00 | (0.72) | 0.00 | 5.38 | 21.63 | |||
ELVN | 2.47 | (0.24) | 0.00 | (0.37) | 0.00 | 4.35 | 19.31 | |||
IKNA | 1.73 | (0.35) | 0.00 | (0.64) | 0.00 | 3.87 | 16.13 | |||
XLO | 7.61 | 0.96 | 0.13 | (0.96) | 7.32 | 12.00 | 137.08 | |||
TARA | 5.77 | 1.19 | 0.23 | 2.78 | 4.44 | 12.86 | 79.13 | |||
SRRK | 3.31 | 0.71 | 0.22 | 0.39 | 2.81 | 6.72 | 31.62 | |||
VACC | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
UroGen Pharma Corporate Management
Dong Kim | Chief Officer | Profile | |
Jason JD | Chief Counsel | Profile | |
Sari PrutchiSagiv | Marketing Director | Profile | |
Jason Smith | Chief Counsel | Profile | |
Bryon Wornson | Advocacy Talent | Profile | |
Eric Zanten | Director Communications | Profile | |
Christopher CPA | Chief Officer | Profile |